In this episode, we discuss potential implications of the Inflation Reduction Act (IRA) legislation that was passed in the U.S. in 2022.

This episode covers:

  • An overview of the IRA in relation to healthcare
  • The potential impacts for oncology patients, manufacturers, and oncologists
  • The impact of the legislation outside of the U.S.


  • Nancy McGee, JD, MPH, DrPH, Senior Vice President, Health Policy & Public Payers, Lumanity
  • Rob Rawlinson, Director, Oncology Insights Lead, Lumanity

©2023 Lumanity Inc.